Healthcare provider profile · identity verified

David W. Wong, MD

Internal Medicine · PANORAMA CITY, CA · NPI 1669549549

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	475	167
Losartan Potassium	Losartan Potassium	380	124
Amlodipine Besylate	Amlodipine Besylate	303	108
Levothyroxine Sodium	Levothyroxine Sodium	260	91
Metformin Hcl	Metformin Hcl	241	80
Lisinopril	Lisinopril	191	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	182	33
Rosuvastatin Calcium	Rosuvastatin Calcium	169	68
Simvastatin	Simvastatin	167	57
Omeprazole	Omeprazole	156	57
Atenolol	Atenolol	150	52
Pantoprazole Sodium	Pantoprazole Sodium	145	45
Pradaxa	Dabigatran Etexilate Mesylate	139	39
Tamsulosin Hcl	Tamsulosin Hcl	135	46
Albuterol Sulfate Hfa	Albuterol Sulfate	122	62
Metoprolol Tartrate	Metoprolol Tartrate	117	40
Glipizide	Glipizide	104	36
Furosemide	Furosemide	103	46
Gabapentin	Gabapentin	94	38
Hydrochlorothiazide	Hydrochlorothiazide	87	33
Jardiance	Empagliflozin	82	27
Metformin Hcl Er	Metformin Hcl	82	29
Ozempic	Semaglutide	77	14
Alprazolam	Alprazolam	76	14
Clopidogrel	Clopidogrel Bisulfate	76	22
Temazepam	Temazepam	75	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	68	22
Carvedilol	Carvedilol	67	20
Finasteride	Finasteride	66	20
Potassium Chloride	Potassium Chloride	66	26
Allopurinol	Allopurinol	64	28
Trazodone Hcl	Trazodone Hcl	60	22
Venlafaxine Hcl Er	Venlafaxine Hcl	60	20
Terazosin Hcl	Terazosin Hcl	59	22
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	55	20
Meloxicam	Meloxicam	53	27
Ezetimibe	Ezetimibe	52	19
Wixela Inhub	Fluticasone Propion/Salmeterol	51	22
Tramadol Hcl	Tramadol Hcl	50	14
Triamcinolone Acetonide	Triamcinolone Acetonide	50	24
Lovastatin	Lovastatin	49	16
Fluoxetine Hcl	Fluoxetine Hcl	47	17
Azelastine Hcl	Azelastine Hcl	46	19
Ipratropium Bromide	Ipratropium Bromide	46	30
Prednisone	Prednisone	46	34
Spironolactone	Spironolactone	43	14
Alendronate Sodium	Alendronate Sodium	42	19
Pioglitazone Hcl	Pioglitazone Hcl	41	15
Cephalexin	Cephalexin	40	34
Ibuprofen	Ibuprofen	40	24
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	39	11
Sertraline Hcl	Sertraline Hcl	38	17
Pravastatin Sodium	Pravastatin Sodium	37	15
Famotidine	Famotidine	36	16
Hydralazine Hcl	Hydralazine Hcl	36	12
Hydroxyzine Hcl	Hydroxyzine Hcl	36	suppressed
Lorazepam	Lorazepam	36	12
Propranolol Hcl	Propranolol Hcl	36	13
Duloxetine Hcl	Duloxetine Hcl	34	14
Bisoprolol Fumarate	Bisoprolol Fumarate	33	11
Montelukast Sodium	Montelukast Sodium	32	suppressed
Azithromycin	Azithromycin	31	27
Verapamil Er	Verapamil Hcl	31	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	30	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	29	suppressed
Nystatin	Nystatin	29	12
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Ondansetron Odt	Ondansetron	26	12
Clonazepam	Clonazepam	25	suppressed
Humulin N	Insulin Nph Human Isophane	25	suppressed
Mirtazapine	Mirtazapine	25	suppressed
Naproxen	Naproxen	25	15
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	25	20
Amoxicillin	Amoxicillin	24	17
Ciprofloxacin Hcl	Ciprofloxacin Hcl	24	15
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	12
Sumatriptan Succinate	Sumatriptan Succinate	24	11
Estradiol	Estradiol	23	13
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Testosterone	Testosterone	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Colchicine	Colchicine	22	15
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	21	21
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	20
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Labetalol Hcl	Labetalol Hcl	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Eliquis	Apixaban	19	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	19	18
Breyna	Budesonide/Formoterol Fumarate	18	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Ropinirole Hcl	Ropinirole Hcl	18	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	17	17
Clonidine Hcl	Clonidine Hcl	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Terbinafine Hcl	Terbinafine Hcl	17	suppressed
Trospium Chloride	Trospium Chloride	17	suppressed
Fluocinonide	Fluocinonide	16	suppressed
Digoxin	Digoxin	15	suppressed
Nitroglycerin	Nitroglycerin	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Diltiazem Hcl	Diltiazem Hcl	14	suppressed
Humulin R	Insulin Regular, Human	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Atropine Sulfate	Atropine Sulfate	12	suppressed
Cartia Xt	Diltiazem Hcl	12	suppressed
Methylprednisolone	Methylprednisolone	12	suppressed
Climara	Estradiol	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error